Multiple Sclerosis - Relapsing Remitting: Clinical Trials

2 trials for Multiple Sclerosis - Relapsing Remitting, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 unknown, 1 withdrawn. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 11Withdrawn 1
Phase 21Withdrawn 1

Follow Multiple Sclerosis - Relapsing Remitting: new trials by email Literature Review of Multiple Sclerosis - Relapsing Remitting trials Research Report on Multiple Sclerosis - Relapsing Remitting

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
RESET-MS: A Study to Evaluate the Safety and Efficacy of CABA-201 in Participants With Multiple Sclerosis
CABA-201 - Relapsing Multiple Sclerosis (RMS), Progressive Multiple Sclerosis (PMS)
Phase 1 / Phase 2WithdrawnCabaletta Bio2026-06-012026-06-25
DTI in Children With Multiple Sclerosis
DTI-MRI - Multiple Sclerosis - Relapsing Remitting, Clinically Isolated Syndrome, CNS Demyelinating
Not applicableUnknownUniversity Hospital Muenster152014-12-012016-05-19

Narrower conditions

Multiple Sclerosis, Relapsing-Remitting (2)  ·  Autoimmune Diseases (1)  ·  Demyelinating Diseases (1)  ·  Multiple Sclerosis (1)  ·  Multiple Sclerosis, Chronic Progressive (1)

Broader conditions

Autoimmune Diseases of the Nervous System (2)  ·  Demyelinating Autoimmune Diseases, CNS (2)  ·  Immune System Diseases (2)  ·  Nervous System Diseases (2)  ·  Autoimmune Diseases (1)  ·  Chronic Disease (1)  ·  Demyelinating Diseases (1)  ·  Disease Attributes (1)  ·  Multiple Sclerosis (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Diffusion Tensor Imaging (1)

Sponsors

Cabaletta Bio (1)  ·  University Hospital Muenster (1)

Countries

Germany (1)

Top investigators

Christiane Elpers, MD (1)